Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Colorectal Neoplasms

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 67 articles:
HTML format



Single Articles


    October 2024
  1. SHI KS, Han X, Star J, Zhao J, et al
    Association of health insurance coverage disruptions and breast and colorectal cancer screening.
    Cancer. 2024 Oct 1. doi: 10.1002/cncr.35584.
    PubMed     Abstract available


    September 2024
  2. BHUTIANI N, Peacock O, Uppal A, Hu CY, et al
    The prognostic impact of tumor deposits in colorectal cancer: More than just N1c.
    Cancer. 2024 Sep 22. doi: 10.1002/cncr.35491.
    PubMed     Abstract available


  3. HE MM, Wang K, Song M
    Reply to "The influence of multivitamin intake on survival patterns in patients with colorectal cancer".
    Cancer. 2024 Sep 15. doi: 10.1002/cncr.35569.
    PubMed    


  4. TANG WZ, Tang Y, Liu TH
    The influence of multivitamin intake on survival patterns in patients with colorectal cancer.
    Cancer. 2024 Sep 14. doi: 10.1002/cncr.35570.
    PubMed    


    August 2024
  5. BEATRICI E, Paciotti M, Nguyen DD, Filipas DK, et al
    Estimating the impact of enhanced care at minority-serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers.
    Cancer. 2024;130:2770-2781.
    PubMed     Abstract available


  6. NIERENGARTEN MB
    Potential new therapy for KRAS-mutated CRC.
    Cancer. 2024;130:2569.
    PubMed    


    July 2024
  7. SUN V, Guthrie KA, Crane TE, Arnold KB, et al
    SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer.
    Cancer. 2024;130:2384-2394.
    PubMed     Abstract available


    May 2024
  8. MARTINEZ ME, Roesch S, Largaespada V, Castaneda SF, et al
    A pragmatic randomized trial of mailed fecal immunochemical testing to increase colorectal cancer screening among low-income and minoritized populations.
    Cancer. 2024 May 25. doi: 10.1002/cncr.35369.
    PubMed     Abstract available


  9. HOEHN RS, Ammori JB, Rothermel LD, Winter JM, et al
    Providing context for the HIPECT4 results.
    Cancer. 2024;130:1727-1729.
    PubMed    


  10. JANCZEWSKI LM, Browner A, Cotler J, Nelson H, et al
    Data-driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancer.
    Cancer. 2024;130:1702-1710.
    PubMed     Abstract available


    April 2024
  11. SIMONI O, Scarpa M, Castagliuolo I, Stepanyan A, et al
    IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer.
    Cancer. 2024 Apr 22. doi: 10.1002/cncr.35297.
    PubMed     Abstract available


  12. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
    National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough.
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35335.
    PubMed    


  13. RUAN Y, Heer E, Brenner DR
    Reply to "National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough".
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35339.
    PubMed    


    February 2024
  14. LIU YL, Weigelt B
    A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancers.
    Cancer. 2024 Feb 29. doi: 10.1002/cncr.35267.
    PubMed     Abstract available


  15. HE MM, Wang K, Lo CH, Zhang Y, et al
    Post-diagnostic multivitamin supplement use and colorectal cancer survival: A prospective cohort study.
    Cancer. 2024 Feb 6. doi: 10.1002/cncr.35234.
    PubMed     Abstract available


    January 2024
  16. BYRD DA, Zouiouich S, Karwa S, Li XS, et al
    Associations of serum trimethylamine N-oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort.
    Cancer. 2024 Jan 29. doi: 10.1002/cncr.35219.
    PubMed     Abstract available


  17. CAAN BJ, Brown JC, Lee C, Binder AM, et al
    Effect of home-based resistance training on chemotherapy relative dose intensity and tolerability in colon cancer: The FORCE randomized control trial.
    Cancer. 2024 Jan 24. doi: 10.1002/cncr.35204.
    PubMed     Abstract available


  18. HALF EE, Levi Z, Mannalithara A, Leshno M, et al
    Colorectal cancer screening at age 45 years in Israel: Cost-effectiveness and global implications.
    Cancer. 2024 Jan 5. doi: 10.1002/cncr.35097.
    PubMed     Abstract available


  19. BYTNAR JA, McGlynn KA, Nealeigh MD, Shriver CD, et al
    Cancer incidence in the US military: An updated analysis.
    Cancer. 2024;130:96-106.
    PubMed     Abstract available


    December 2023
  20. AREVALO M, Sutton SK, Abdulla R, Christy SM, et al
    Longitudinal adherence to annual colorectal cancer screening among Black persons living in the United States enrolled in a community-based randomized trial.
    Cancer. 2023 Dec 27. doi: 10.1002/cncr.35169.
    PubMed     Abstract available


  21. EOM KY, Koroukian SM, Dong W, Kim U, et al
    Accounting for Medicaid expansion and regional policy and programs to advance equity in cancer prevention in the United States.
    Cancer. 2023;129:3915-3927.
    PubMed     Abstract available


    November 2023
  22. YANG K, Doege D, Thong MSY, Koch-Gallenkamp L, et al
    Diabetes mellitus in long-term survivors with colorectal, breast, or prostate cancer: Prevalence and prognosis. A population-based study.
    Cancer. 2023 Nov 23. doi: 10.1002/cncr.35133.
    PubMed     Abstract available


    October 2023
  23. MAHAR AL, Biggs K, Hansford RL, Derksen S, et al
    Stage IV breast, colorectal, and lung cancer at diagnosis in adults living with intellectual or developmental disabilities: A population-based cross-sectional study.
    Cancer. 2023 Oct 30. doi: 10.1002/cncr.35068.
    PubMed     Abstract available


  24. HSU HY, Chern YJ, Hsu MS, Yeh TL, et al
    Diabetic severity and oncological outcomes of colorectal cancer following curative resection: A population-based cohort study in Taiwan diabetes and colorectal cancer prognosis.
    Cancer. 2023 Oct 23. doi: 10.1002/cncr.34975.
    PubMed     Abstract available


  25. VAN TUIJL LA, Basten M, Pan KY, Vermeulen R, et al
    Depression, anxiety, and the risk of cancer: An individual participant data meta-analysis.
    Cancer. 2023;129:3287-3299.
    PubMed     Abstract available


  26. TAMMEMAGI MC, Cina K, Kitts AKB, Koop D, et al
    Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self-reporting as Indigenous and non-Indigenous.
    Cancer. 2023 Oct 9. doi: 10.1002/cncr.34947.
    PubMed     Abstract available


    September 2023
  27. RIEDINGER CJ, Esnakula A, Haight PJ, Suarez AA, et al
    Characterization of mismatch-repair (MMR)/microsatellite instability (MSI)-discordant endometrial cancers.
    Cancer. 2023 Sep 26. doi: 10.1002/cncr.35030.
    PubMed     Abstract available


  28. MALCOMSON FC, Wiggins C, Parra-Soto S, Ho FK, et al
    Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and cancer risk: A systematic review and meta-analysis.
    Cancer. 2023;129:2655-2670.
    PubMed     Abstract available


    August 2023
  29. BROWN JC, Ma C, Shi Q, Zemla T, et al
    Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance).
    Cancer. 2023 Aug 31. doi: 10.1002/cncr.35007.
    PubMed     Abstract available


  30. TRILLA-FUERTES L, Gamez-Pozo A, Nogue M, Busquier I, et al
    Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.
    Cancer. 2023;129:2581-2592.
    PubMed     Abstract available


  31. ISLAMI F, Wiese D, Marlow EC, Kratzer TB, et al
    Progress in reducing cancer mortality in the United States by congressional district, 1996-2003 to 2012-2020.
    Cancer. 2023;129:2522-2531.
    PubMed     Abstract available


    June 2023
  32. NIERENGARTEN MB
    New standard of care for refractory metastatic colorectal cancer.
    Cancer. 2023;129:1789-1790.
    PubMed    


  33. MOORADIAN MJ, Cleary JM, Giobbie-Hurder A, Darville LNF, et al
    Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors.
    Cancer. 2023;129:1904-1918.
    PubMed     Abstract available


    May 2023
  34. SPENCER JC, Noel L, Shokar NK, Pignone MP, et al
    Understanding the role of access in Hispanic cancer screening disparities.
    Cancer. 2023;129:1569-1578.
    PubMed     Abstract available


  35. KNUDSEN MD, Wang K, Berstad P, Polychronidis G, et al
    Use of surveillance colonoscopy among individuals with removal of high-risk polyps according to the US Multi-Society Task Force recommendations.
    Cancer. 2023;129:1394-1401.
    PubMed     Abstract available


    April 2023
  36. CHOI DW, Kang H, Zhang HS, Jhang H, et al
    Association of polypharmacy with all-cause mortality and adverse events among elderly colorectal cancer survivors.
    Cancer. 2023 Apr 28. doi: 10.1002/cncr.34813.
    PubMed     Abstract available


  37. GREEN BB
    Defensive information processing and nonadherence to health-protective behaviors.
    Cancer. 2023;129:1156-1158.
    PubMed     Abstract available


    March 2023
  38. NIERENGARTEN MB
    Association of physical exercise and a healthy gut microbiome in colorectal cancer.
    Cancer. 2023;129:655-656.
    PubMed    


    February 2023
  39. WITMER HDD, Dhiman A, Turaga KK
    Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?
    Cancer. 2023;129:495-502.
    PubMed     Abstract available


  40. CLARKE N, Hayes L, McQueen A, Gallagher P, et al
    The role of defensive information processing in population-based colorectal cancer screening uptake.
    Cancer. 2023 Feb 6. doi: 10.1002/cncr.34603.
    PubMed     Abstract available


  41. NIERENGARTEN MB
    Colonoscopy remains the gold standard for screening despite recent tarnish: Although a recent study seemed to indicate that colonoscopies are not as effective as once thought at detecting colorectal cancer, a closer look at the study clears the confus
    Cancer. 2023;129:330-331.
    PubMed    


    January 2023
  42. HAN L, Boyle JM, Walker K, Kuryba A, et al
    Impact of patient choice and hospital competition on patient outcomes after rectal cancer surgery: A national population-based study.
    Cancer. 2023;129:130-141.
    PubMed     Abstract available


    September 2022

  43. Screening before age 50 years can significantly reduce women's colorectal cancer incidence.
    Cancer. 2022;128:3276-3277.
    PubMed    


  44. SNYDER RA, Hu CY, DiBrito SR, Chang GJ, et al
    Association of Medicaid expansion with racial disparities in cancer stage at presentation.
    Cancer. 2022;128:3340-3351.
    PubMed     Abstract available


  45. GANZ PA, Hays RD, Spritzer KL, Rogatko A, et al
    Health-related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R-04.
    Cancer. 2022;128:3233-3242.
    PubMed     Abstract available


    August 2022
  46. RIEDEL RF, Agulnik M
    Evolving strategies for management of desmoid tumor.
    Cancer. 2022;128:3027-3040.
    PubMed     Abstract available


    July 2022
  47. DWYER AJ, Weltzien ES, Harty NM, LeGrice KE, et al
    What makes for successful patient navigation implementation in cancer prevention and screening programs using an evaluation and sustainability framework.
    Cancer. 2022;128 Suppl 13:2636-2648.
    PubMed     Abstract available


    June 2022
  48. BHUTIANI N, Peacock O, Chang GJ
    A practical framework for the targeted use of total neoadjuvant therapy for rectal cancer.
    Cancer. 2022;128:2064-2072.
    PubMed     Abstract available


  49. JOUNG RH, Nelson H, Mullett TW, Kurtzman SH, et al
    A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Cancer. 2022;128:2119-2125.
    PubMed     Abstract available


    May 2022
  50. O'ROURKE K
    Periodontal disease linked to an increase in colorectal cancer.
    Cancer. 2022;128:1723.
    PubMed    


    March 2022
  51. SALTZ LB
    Top advances of the year in colorectal cancer.
    Cancer. 2022 Mar 24. doi: 10.1002/cncr.34185.
    PubMed     Abstract available


  52. PEDERSEN SK, Musher BL, LaPointe LC, Tuck MK, et al
    Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1.
    Cancer. 2022 Mar 15. doi: 10.1002/cncr.34159.
    PubMed     Abstract available


  53. LEBECK LEE CM, Ziogas IA, Agarwal R, Alexopoulos SP, et al
    A contemporary systematic review on liver transplantation for unresectable liver metastases of colorectal cancer.
    Cancer. 2022 Mar 14. doi: 10.1002/cncr.34170.
    PubMed     Abstract available


  54. KOROUKIAN SM, Zhou G, Navale SM, Schiltz NK, et al
    Excess cancer prevalence in men with HIV: A nationwide analysis of Medicaid data.
    Cancer. 2022 Mar 14. doi: 10.1002/cncr.34166.
    PubMed     Abstract available


    February 2022
  55. WINKLER CS, Hardaway JC, Ceyhan ME, Espat NJ, et al
    Decreasing colorectal cancer screening disparities: A culturally tailored patient navigation program for Hispanic patients.
    Cancer. 2022 Feb 7. doi: 10.1002/cncr.34112.
    PubMed     Abstract available


    January 2022
  56. SELMOUNI F, Amrani L, Sauvaget C, Bakkar M, et al
    Delivering colorectal cancer screening integrated with primary health care services in Morocco: Lessons learned from a demonstration project.
    Cancer. 2022 Jan 5. doi: 10.1002/cncr.34061.
    PubMed     Abstract available


  57. CORONADO GD
    Sustainable infrastructure and risk stratification are needed to appropriately deliver colorectal cancer screening globally.
    Cancer. 2022 Jan 5. doi: 10.1002/cncr.34059.
    PubMed    


    December 2021
  58. CONWAY RE, Rigler FV, Croker HA, Lally PJ, et al
    Dietary supplement use by individuals living with and beyond breast, prostate, and colorectal cancer: A cross-sectional survey.
    Cancer. 2021 Dec 20. doi: 10.1002/cncr.34055.
    PubMed     Abstract available


  59. ANTILL Y, Buchanan DD, Scott CL
    Mismatch repair and clinical response to immune checkpoint inhibitors in endometrial cancer.
    Cancer. 2021 Dec 7. doi: 10.1002/cncr.34024.
    PubMed     Abstract available


    November 2021
  60. JAVIER-DESLOGES J, Nelson TJ, Murphy JD, McKay RR, et al
    Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
    Cancer. 2021 Nov 22. doi: 10.1002/cncr.33991.
    PubMed     Abstract available


  61. TRAN TT, Gunathilake M, Lee J, Kim J, et al
    Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study.
    Cancer. 2021 Nov 11. doi: 10.1002/cncr.34027.
    PubMed     Abstract available


  62. TCHELEBI LT, Shen B, Wang M, Gusani NJ, et al
    Impact of radiation therapy facility volume on survival in patients with cancer.
    Cancer. 2021;127:4081-4090.
    PubMed     Abstract available


    October 2021
  63. BENSON AB 3RD, Carlos RC
    Clinical trials as a path toward equity.
    Cancer. 2021;127:3717-3719.
    PubMed    


    September 2021
  64. BALDWIN LM, Coronado GD, West II, Schwartz MR, et al
    Health plan-based mailed fecal testing for colorectal cancer screening among dual-eligible Medicaid/Medicare enrollees: Outcomes of 2 program models.
    Cancer. 2021 Sep 29. doi: 10.1002/cncr.33909.
    PubMed     Abstract available


    May 2021
  65. KIM SR, Tone A, Kim RH, Cesari M, et al
    Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer.
    Cancer. 2021 May 13. doi: 10.1002/cncr.33625.
    PubMed     Abstract available


    April 2021
  66. BUTLER SS, Mahal BA, Moslehi JJ, Nohria A, et al
    Risk of cardiovascular mortality with androgen deprivation therapy in prostate cancer: A secondary analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Controlled Trial.
    Cancer. 2021 Apr 27. doi: 10.1002/cncr.33486.
    PubMed     Abstract available


    March 2021
  67. BALACHANDRA S, Kusin SB, Lee R, Blackwell JM, et al
    Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
    Cancer. 2021;127:850-864.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.